Rohto Pharmaceutical operates its core skincare business in more than 115 countries, finely tailoring its formulations to differences in each country's ingredient regulations and lifestyles. It has also outlined efforts to bring the science of J-Beauty to overseas markets.
Rohto Pharmaceutical operates its core skincare brands in more than 115 countries, fine-tuning its formulations to suit each country's regulations, climate and lifestyle while maintaining globally shared core ingredients and brand philosophy. The company has been introduced as designing products to reflect the characteristics of each regional market.
The head of its Product & Brand Marketing Division said that the appeal of the science of J-Beauty lies not in simply adopting trending ingredients, but in elucidating how the skin works and maximising the efficacy of those ingredients. The company is also drawing on its expertise in regenerative medicine research to communicate the Japan-originated concept of longevity overseas. At the same time, it has stated a policy of expanding the concepts of healthy longevity and wellbeing through its overseas operations.
The article describes Rohto Pharmaceutical's overseas market strategy and approach to research and development. It refers to the company's intention to expand the scope of its beauty business by popularising longevity, as well as its use of technologies such as phytoexosome research as new points of entry. Although the article gives no specific country names or fiscal-year figures, its key message is the company's policy of global expansion.